Select Therapeutics announces research agreement with University of Arizona Cancer Center.(Brief Article)

SELECT Therapeutics Inc. (Cambridge, MA) announced that it has entered into a research agreement with the University of Arizona Cancer Center (Tucson, AZ) for "Evaluation of Therapeutic Vaccines for Cancer Patients." Evan Hersh, MD, professor of medicine and assistant director of experimental therapeutics and translational research at ACC will serve as principal investigator. He is a member of SELECT's Scientific Advisory Board and has a distinguished research and clinical development record in the field of novel anti-cancer strategies. The Arizona Cancer Center is a National Cancer Institute-Designated Comprehensive Cancer Center at The University of Arizona Health …